Avai Bio delays filing annual report for year ended March 31, 2026

AVANT TECHNOLOGIES INC

AVANT TECHNOLOGIES INC

AVAI

0.00
  • Avai Bio filed a Form 12b-25, delaying its Form 10-K for the fiscal year ended March 31, 2026.
  • The filing missed its deadline due to extra time needed to prepare and compile financial statements and related disclosures.
  • The company expects to file the annual report within the 15-day extension period allowed under SEC Rule 12b-25.
  • It did not anticipate a significant change in results of operations versus the prior-year period.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avai Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001740797-26-000013), on June 30, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.